Economic evaluation for early hemoperfusion in the treatment of acute organophosphate poisoning
10.3760/cma.j.issn.1673-4904.2014.04.007
- VernacularTitle:早期血液灌流在急性有机磷农药中毒患者治疗中的经济学评价
- Author:
Ying WU
- Publication Type:Journal Article
- Keywords:
Poisoning;
Organophosphorus compounds;
Hemoperfusion
- From:
Chinese Journal of Postgraduates of Medicine
2014;37(4):23-25
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate early hemopeffusion in the patients of acute organophosphate poisoning from economic.Methods Forty patients with acute organophosphate poisoning were divided into early hemoperfusion group (20 cases) and control group (20 cases) according to the condition of early hemoperfusion in three hours after the diagnosis.The date of basal clinical conditions,treatment,prognosis and cost in the 2 groups were observed.Results There were no statistical differences in sex,age,the level of initial acetylcholine esterase (ChE) and degree of poisoning between the 2 groups (P ＞ 0.05).The patients of the 2 groups underwent at least 1 time hemoperfusion.The time of beginning hemoperfusion in early hemoperfusion group and control group were (1.6 ±0.9) h and (6.4 ±3.6) h,and there was statistical difference (P ＜0.05).The time of ChE recovery and length of stay in early hemoperfusion group were significantly lower than those in control group [(8.5 ± 2.1) d vs.(10.0 ± 1.8) d,(10.5 ± 4.2) d vs.(12.3 ± 5.4) d],and there were statistical differences (P ＜0.05).In early hemoperfusion group 5 cases needed rehemoperfusion,and 4 cases needed mechanical ventilation,in control group were 8 and 5 cases respectively.There was no death in the duration of hospital stay and during 28 d in early hemoperfusion group,but in control group death in the duration of hospital stay was 1 case and death during 28 d was 1 case.The total hospitalization cost,daily treatment cost,health care cost and drug cost in early hemoperfusion group were significantly lower than those in control group [(17 231.75 ± 5 411.45) yuan vs.(21 394.52 ± 6 049.81)yuan,(1 412.25 ±169.33) yuan vs.(1 579.41 ±307.19) yuan,(4 309.22 ±1 490.12)yuan vs.(5 581.71 ± 1 681.00) yuan,(8 223.41 ± 1 426.10) yuan vs.(9 790.02 ± 1 909.24) yuan],and there were statistical differences (P ＜ 0.05).Conclusion The patients of acute organophosphate poisoning could be benefit from early hemoperfusion,because early hemoperfusion can shorten the recovery time of ChE,the length of stay,and reduce the hospitalization cost.
